219 related articles for article (PubMed ID: 23082819)
1. A comprehensive morphological study for basal-like breast carcinomas with comparison to nonbasal-like carcinomas.
Cakir A; Gonul II; Uluoglu O
Diagn Pathol; 2012 Oct; 7():145. PubMed ID: 23082819
[TBL] [Abstract][Full Text] [Related]
2. Metaplastic breast carcinomas and their relationship with basal-like phenotype.
Cakir A; Gönül II; Uluoğlu O
Turk Patoloji Derg; 2012; 28(2):134-41. PubMed ID: 22627631
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.
Livasy CA; Karaca G; Nanda R; Tretiakova MS; Olopade OI; Moore DT; Perou CM
Mod Pathol; 2006 Feb; 19(2):264-71. PubMed ID: 16341146
[TBL] [Abstract][Full Text] [Related]
4. P-cadherin and vimentin are useful basal markers in breast cancers.
Tsang JY; Au SK; Ni YB; Shao MM; Siu WM; Hui SW; Chan SK; Chan KW; Kwok YK; Chan KF; Tse GM
Hum Pathol; 2013 Dec; 44(12):2782-91. PubMed ID: 24139214
[TBL] [Abstract][Full Text] [Related]
5. Triple-Negative Breast Cancer: A Comprehensive Study of Clinical, Histomorphological, and Immunohistochemical Features in Indian Patients.
Sable M; Pai TD; Shet T; Patil A; Dhanavade S; Desai SB
Int J Surg Pathol; 2017 May; 25(3):230-237. PubMed ID: 27612858
[TBL] [Abstract][Full Text] [Related]
6. Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum.
Laé M; Fréneaux P; Sastre-Garau X; Chouchane O; Sigal-Zafrani B; Vincent-Salomon A
Mod Pathol; 2009 Feb; 22(2):291-8. PubMed ID: 19011601
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of GATA3 expression in invasive breast cancer: differences in histological subtypes and immunohistochemically defined molecular subtypes.
Shaoxian T; Baohua Y; Xiaoli X; Yufan C; Xiaoyu T; Hongfen L; Rui B; Xiangjie S; Ruohong S; Wentao Y
J Clin Pathol; 2017 Nov; 70(11):926-934. PubMed ID: 28428285
[TBL] [Abstract][Full Text] [Related]
8. Nerve growth factor receptor (NGFR): a potential marker for specific molecular subtypes of breast cancer.
Tsang JY; Wong KH; Lai MW; Lacambra MD; Ko CW; Chan SK; Lam CC; Yu AM; Tan PH; Tse GM
J Clin Pathol; 2013 Apr; 66(4):291-6. PubMed ID: 23268325
[TBL] [Abstract][Full Text] [Related]
9. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
10. Fine-needle aspiration cytology of triple-negative basal-like breast cancer.
Akashi S; Kuwabara H; Kurisu Y; Takahashi Y; Yasuda E; Takeshita A; Ishizaki S; Tsuji M; Shibayama Y
Diagn Cytopathol; 2013 Apr; 41(4):283-7. PubMed ID: 21987494
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathologic characteristics of breast cancer with basal-like immunophenotype].
Wu WX; Han WL; Zhang YP; Yu QX; Wen XW; Lu N; Tang ZY; Yuan LN; Zhang Y; Wang Z; Wang W; Yang HJ; Chen CP; Guo WL
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):743-8. PubMed ID: 19094708
[TBL] [Abstract][Full Text] [Related]
12. Triple-negative breast carcinomas are a heterogeneous entity that differs between young and old patients.
Carvalho FM; Bacchi LM; Santos PP; Bacchi CE
Clinics (Sao Paulo); 2010; 65(10):1033-6. PubMed ID: 21120307
[TBL] [Abstract][Full Text] [Related]
13. Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.
Rakha EA; Elsheikh SE; Aleskandarany MA; Habashi HO; Green AR; Powe DG; El-Sayed ME; Benhasouna A; Brunet JS; Akslen LA; Evans AJ; Blamey R; Reis-Filho JS; Foulkes WD; Ellis IO
Clin Cancer Res; 2009 Apr; 15(7):2302-10. PubMed ID: 19318481
[TBL] [Abstract][Full Text] [Related]
14. Basal-like immunophenotype markers and prognosis in early breast cancer.
Cassol L; Silveira Graudenz M; Zelmanowicz A; Cancela A; Werutsky G; Rovere RK; Garicochea B
Tumori; 2010; 96(6):966-70. PubMed ID: 21388060
[TBL] [Abstract][Full Text] [Related]
15. Cytologic features of triple-negative breast carcinoma.
Bonzanini M; Morelli L; Bonandini EM; Leonardi E; Pertile R; Dalla Palma P
Cancer Cytopathol; 2012 Dec; 120(6):401-9. PubMed ID: 22833438
[TBL] [Abstract][Full Text] [Related]
16. A mitotically active, cellular tumor stroma and/or inflammatory cells associated with tumor cells may contribute to intermediate or high Oncotype DX Recurrence Scores in low-grade invasive breast carcinomas.
Acs G; Esposito NN; Kiluk J; Loftus L; Laronga C
Mod Pathol; 2012 Apr; 25(4):556-66. PubMed ID: 22173289
[TBL] [Abstract][Full Text] [Related]
17. Inference of the Basal epithelial phenotype in breast carcinoma from differential marker expression, using tissue microarrays in triple negative breast cancer and women younger than 35.
Nassar A; Sussman ZM; Lawson D; Cohen C
Breast J; 2012 Sep; 18(5):399-405. PubMed ID: 22882580
[TBL] [Abstract][Full Text] [Related]
18. Metaplastic carcinoma of the breast: an immunohistochemical study.
Altaf FJ; Mokhtar GA; Emam E; Bokhary RY; Mahfouz NB; Al Amoudi S; Al-Gaithy ZK
Diagn Pathol; 2014 Jul; 9():139. PubMed ID: 25030022
[TBL] [Abstract][Full Text] [Related]
19. Comparison of metastatic neuroendocrine neoplasms to the breast and primary invasive mammary carcinomas with neuroendocrine differentiation.
Mohanty SK; Kim SA; DeLair DF; Bose S; Laury AR; Chopra S; Mertens RB; Dhall D
Mod Pathol; 2016 Aug; 29(8):788-98. PubMed ID: 27125358
[TBL] [Abstract][Full Text] [Related]
20. p16 expression correlates with basal-like triple-negative breast carcinoma.
Abou-Bakr AA; Eldweny HI
Ecancermedicalscience; 2013; 7():317. PubMed ID: 23717338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
